News
Yemaachi News
October 1, 2021
The fourth issue of the Yemaachi Bulletin covers Yemaachi’s participation in the S21 batch of the Y Combinator as well as a Key Partnership to raise […]
August 31, 2021
Tech Crunch profiles Yemaachi Biotech and the other 14 African Startups that were selected to be a part of Y Combinator's summer batch of 2021.
July 1, 2021
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab
July 1, 2021
The third issue of the Yemaachi Bulletin covers a key milestone marked by Yemaachi as well as other activities from the past 3 months
May 30, 2021
The Holistic Drug Discovery and Development (H3D) Centre at the University of Cape Town (UCT) has entered into a strategic partnership with Yemaachi Biotech, to exploit African genetic diversity by identifying new therapies and platforms that optimize cancer treatments for African patient populations.
March 31, 2021
The second issue of the Yemaachi Bulletin covers an exciting new platform and a promising collaboration, as well as other activities from the past 3 months
February 19, 2021
Yaw Bediako, PhD joined a distinguished panel of Ghana’s healthcare leaders and government representatives to engage the public on the nation’s COVID-19 vaccine roll out plan. […]
December 16, 2020
Dr. Ella Amoako, Desmond Jumbam and Dr. Yaw Bediako authored an editorial in the January 2021 edition of BMJ Global Health, discussing the impact that excluding African participants from clinical trials has on childhood cancer research.
December 14, 2020
The maiden edition of the Yemaachi Bulletin reveals the progress we made so far with fitting out a new space for our lab, and an introduces of a new Google-sponsored project.